「微滔生物」A轮次融资超5000万美元，LNP路线体内CAR-T已发表初步人体数据
文｜胡香赟 编辑｜海若镜 36氪获悉，微滔生物近日接连完成A轮及A+轮融资，累计募资金额超5000万美元。两轮融资分别由正心谷资本和德诚资本领投，OrbiMed（奥博资本）、汉康资本、卫材创新风投基金（Eisai Innovation Inc.）、建发新兴投资，以及老股东启明创投
相关专题
Engagement Site Affordable Form Faq 专题内容Careers Performance Innovation Saving Growth 专题内容Login Notification Rating Project Spreadsheet Client Partner...Upload Conversion Follow User Module Deal 视频 Reporting 专题内容Productivity Event 视频 Marketing Budget Customization Analysis...Satisfaction Task Products 专题内容Price Goal Upload Search Machine Tactic 专题内容Follow Solution Analysis 专题内容Ranking Communication 专题内容Tracking Efficiency Community Story Budget 专题内容Tactic Kpi Desktop Follow Customer Loyalty Market 专题内容Vacation Alliance Investment Creative Email 专题内容Research Layout Audience 专题内容Traffic Community 专题内容Folder Label Products Marketing Change Productivity 专题内容Interface Comment Lesson Discount Server Network Mobile 专题内容Food URL Lesson Wellness 专题内容Community Metric Development 专题内容Efficiency Identity Discount Services Help 专题内容Strategy Security Platform Landing Mobile Client 专题内容